Dr. Zoltick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Abramson Bldg Rm 1116A
Philadelphia, PA 19104Phone+1 215-590-4656
Education & Training
- University of Rochester School of Medicine and DentistryClass of 1975
Certifications & Licensure
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 145 citationsIn utero CRISPR-mediated therapeutic editing of metabolic genes.Avery C. Rossidis, John D. Stratigis, Alexandra C. Chadwick, Heather A. Hartman, Nicholas J. Ahn
Nature Medicine. 2018-10-08 - 1 citationsTyrosine 870 of TLR9 is critical for receptor maturation rather than phosphorylation-dependent ligand-induced signaling.Chhanda Biswas, Sheila Rao, Katharine Slade, David Hyman, Devin Dersh
Plos One. 2018-07-19 - 17 citations"Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumorsNisha G. Sosale, Irena I. Ivanovska, Richard K. Tsai, Joe Swift, Jake Hsu
Molecular Therapy. Methods & Clinical Development. 2016-01-01
Journal Articles
- In Utero CRISPR-Mediated Therapeutic Editing of Metabolic GenesWilliam H Peranteau, Philip W Zoltick, Kiran Musunuru, William Zacharias, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: